chr12-132618781-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_170682.4(P2RX2):c.-36T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.118 in 1,196,890 control chromosomes in the GnomAD database, including 9,071 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.090 ( 837 hom., cov: 29)
Exomes 𝑓: 0.12 ( 8234 hom. )
Consequence
P2RX2
NM_170682.4 5_prime_UTR
NM_170682.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.465
Genes affected
P2RX2 (HGNC:15459): (purinergic receptor P2X 2) The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel. Binding to ATP mediates synaptic transmission between neurons and from neurons to smooth muscle. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-132618781-T-C is Benign according to our data. Variant chr12-132618781-T-C is described in ClinVar as [Benign]. Clinvar id is 508567.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RX2 | NM_170682.4 | c.-36T>C | 5_prime_UTR_variant | 1/11 | ENST00000643471.2 | NP_733782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RX2 | ENST00000643471.2 | c.-36T>C | 5_prime_UTR_variant | 1/11 | NM_170682.4 | ENSP00000494644 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0904 AC: 13540AN: 149772Hom.: 837 Cov.: 29
GnomAD3 genomes
AF:
AC:
13540
AN:
149772
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.108 AC: 697AN: 6430Hom.: 45 AF XY: 0.110 AC XY: 359AN XY: 3262
GnomAD3 exomes
AF:
AC:
697
AN:
6430
Hom.:
AF XY:
AC XY:
359
AN XY:
3262
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.122 AC: 127316AN: 1047008Hom.: 8234 Cov.: 28 AF XY: 0.121 AC XY: 60099AN XY: 496372
GnomAD4 exome
AF:
AC:
127316
AN:
1047008
Hom.:
Cov.:
28
AF XY:
AC XY:
60099
AN XY:
496372
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0903 AC: 13536AN: 149882Hom.: 837 Cov.: 29 AF XY: 0.0903 AC XY: 6607AN XY: 73184
GnomAD4 genome
AF:
AC:
13536
AN:
149882
Hom.:
Cov.:
29
AF XY:
AC XY:
6607
AN XY:
73184
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at